Company intelligence / Profile preview

UCB Celltech

Slough, Berkshire, United Kingdomucbpharma.co.uk ↗
Ownership
Private
Employees
~700
Development stage
Other
01

Overview

UCB Celltech is the UK-based biopharmaceutical research and development hub of the global pharmaceutical company UCB. Originally established in 1980 as Celltech, it was the UK's pioneer and largest biotechnology firm before being acquired by UCB in 2004 for approximately $2.7 billion. Operating out of Slough, Berkshire, UCB Celltech focuses on discovering and developing innovative antibody-based therapies for severe immunological and neurological conditions. The site leverages advanced automated antibody discovery platforms and fragment-based architectures to fuel UCB's global pipeline. Notable treatments developed or co-developed through its research include Cimzia for rheumatoid arthritis, Evenity for osteoporosis, and Bimzelx for plaque psoriasis.

Therapeutic areas
GastroenterologyDermatologyNeurologyImmunologyEndocrinologyRheumatology
Modalities
Monoclonal antibodyMonoclonal antibody fragmentBispecific monoclonal antibodyBiologicSmall molecule
Industry
Biotech
02

Partnerships

BiogenAmgenBayerGenentech

Beyond the preview

Go deeper on UCB Celltech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on UCB Celltech.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call